Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA

被引：0

作者：

Lang Zheng

Wenjing Wang

Qiu Sun

机构：

[1] West China Hospital,Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy

[2] Sichuan University,West China Medical Publishers, West China Hospital

[3] Sichuan University,undefined

来源：

Signal Transduction and Targeted Therapy | / 9卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] 2011 FDA drug approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2012, 11 (2) : 91 - 94
[22] 2008 FDA drug approvals
Bethan Hughes
[J]. Nature Reviews Drug Discovery, 2009, 8 : 93 - 96
[23] 2009 FDA drug approvals
Bethan Hughes
[J]. Nature Reviews Drug Discovery, 2010, 9 : 89 - 92
[24] 2018 FDA drug approvals
Mullard, Asher
[J]. NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (02) : 85 - 89
[25] 2009 FDA drug approvals
Hughes, Bethan
[J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (02) : 89 - 92
[26] 2019 FDA drug approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2020, 19 (2) : 79 - 84
[27] 2012 FDA drug approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2013, 12 : 87 - 90
[28] 2017 FDA drug approvals
Mullard A.
[J]. Nature Reviews Drug Discovery, 2018, 17 (2) : 81 - 85
[29] 2013 FDA drug approvals
Mullard, Asher
[J]. NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (02) : 85 - 89
[30] 2016 FDA drug approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2017, 16 : 73 - 76